The delayed gastric emptying induced by GLP-1 medications means food remains in the stomach for longer periods
This is the foundation formula
Who might benefit most: People whove had partial response to current GLP-1 therapy Patients who need stronger appetite/satiety support Those who want an option that may compete with (or exceed) todays injectable results, depending on final labeled data 3) Retatrutide (triple G) a triple-hormone incretin approach What it is: Retatrutide is a triple hormone receptor agonist (GLP-1, GIP, and glucagon)
Common side effectsand simple fixes Typical: nausea , constipation , diarrhea , bloating , heartburn , fatigue , injection-site tenderness
The slides were stained with Mayers hematoxylin for 1520 min and eosin for 1 min
Featuring innovative GLP-1 receptor agonist medications like Semaglutide and Tirzepatide, combined with customized nutrition and exercise strategies, our program offers a well-rounded solution to weight management